News
Postmenopausal women on tirzepatide show lower weight loss than those typically seen with the obesity drug, but weight loss ...
In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious ...
For adults with obesity treated with once-weekly tirzepatide, cardiometabolic risk factor improvements were positively ...
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, ...
In patients with obesity, tirzepatide improved cardiometabolic parameters and risk for cardiovascular disease, but the ...
Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...
1d
The Brighterside of News on MSNWeight-loss drug Tirzepatide significantly slows breast cancer growth, study findsKey Takeaways ・The weight-loss drug tirzepatide reduced both body fat and tumor growth in obese mice with breast cancer.
Weight loss jabs such as Wegovy and Mounjaro may offer a protective effect against dementia and stroke, according to a new ...
Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results